FGF21 and metabolic dysfunction-associated steatotic liver disease: On the other hand, other altered hepatokine and adipokine profiles in NAFLD subjects, including fetuin-A, SeP, RBP4, and FGF21, have been increasingly recognized to induce systemic IR by impairing insulin signaling, activating proinflammatory signaling and affecting lipid and glucose metabolism disorders.